Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

Sjögren’s Disease: More Than Just a Syndrome

Jason Liebowitz, MD, FACR  |  August 26, 2025

A EULAR 2025 review of Sjögren’s disease covered new pathogenic insights & promising phase 2 data for BTK inhibitors & CD40 pathway drugs.

Filed under:ConditionsEULAR/OtherMeeting ReportsSjögren’s Disease Tagged with:dazodalibepEULAR 2025iscalimabsalivary glandsSjögren’s Disease supplement

How to Diagnose Sjögren’s Disease

Samantha C. Shapiro, MD  |  August 26, 2025

Improve your Sjögren’s disease diagnosis. Experts discuss objective testing, seronegative cases, ILD screening & management strategies.

Filed under:ConditionsGuidancePractice SupportSjögren’s Disease Tagged with:biopsyDry eyeDry MouthDysautonomiaFibromyalgiaInterstitial Lung DiseaselymphomasiccaSjögren’s Disease supplementUltrasound

How the Experts Treat Sjögren’s Disease

Samantha C. Shapiro, MD  |  August 26, 2025

With no FDA-approved drugs for Sjögren’s disease, experts share strategies for managing fatigue, arthritis, dryness, and systemic issues.

Filed under:Biologics/DMARDsConditionsDrug UpdatesSjögren’s Disease Tagged with:Clinical Practice GuidelinesDry eyeDry MouthfatigueHYDROXYCHLOROQUINEInterstitial Lung DiseaseMethotrexateneuropathyshared decision makingSjögren’s Disease supplement

Dazodalibep for Sjögren’s Disease

Michele B. Kaufman, PharmD, BCGP  |  August 26, 2025

St.Clair et al. found that patients with Sjögren’s disease treated with dazodalibep experienced greater improvement in key symptoms of dryness, fatigue & pain than patients who received placebo.

Filed under:Biologics/DMARDsConditionsDrug UpdatesSjögren’s Disease Tagged with:adverse eventsclinical trialsdazodalibepDry eyefatiguePainSjögren’s Disease supplement

Small Fiber Neuropathy: What the Rheumatologist Needs to Know

Michael Cammarata, MD  |  August 26, 2025

An expert on peripheral neuropathy shares his practical approach to the diagnosis & management of small fiber neuropathy

Filed under:AnalgesicsConditionsDrug UpdatesPain SyndromesSjögren’s Disease Tagged with:antidepressantsbiopsyFibromyalgianeuropathyPainPain ManagementPeripheral NeuropathypregabalinSarcoidosisSjögren’s Disease supplementsmall fiber neuropathy

New FDA Label Requirements for Opioids

Michele B. Kaufman, PharmD, BCGP  |  August 26, 2025

After reviewing data from post-marketing observational studies, the FDA has issued new labeling requirements for opioids with the goal of emphasizing and explaining the risks associated with long-term use.

Filed under:AnalgesicsDrug Updates Tagged with:Chronic painFDAopioidU.S. Food and Drug Administration (FDA)

Preventive Strategies & Novel Treatments for RA

Jason Liebowitz, MD, FACR  |  August 25, 2025

Dr. Diane van der Woude reviewed provided a detailed review of the latest research on rheumatoid arthritis, addressing findings on disease prevention, supplements, novel treatments and much more.

Filed under:ConditionsEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:dietary supplementEULAR 2025patient carepreventionRA Resource CenterRheumatoid Arthritis (RA)Vitamin Dvitamin D supplementation

Encourage Physical Activity During Rheumatic Disease Awareness Month

Vanessa Caceres  |  August 25, 2025

This year’s Rheumatic Disease Awareness Month encourages rheumatology professionals to collaborate with patients on physical activity routines that benefit their health.

Filed under:Conditions Tagged with:Exercisepatient careRDAMRheumatic Disease Awareness Month (RDAM)

What ASTP/ONC’s 2025 Regulations Mean for Rheumatologists

From the College  |  August 22, 2025

The ASTP/ONC’s recently updated United States Core Data for Interoperability Version 6 includes new data elements and applicable standards to support the provision of precision medicine and better patient care across the healthcare system.

Filed under:Information Technology Tagged with:USCDI v6

Case Report: Pulmonary Artery Stenosis Secondary to Granulomatosis with Polyangiitis

Sambhawana Bhandari, MD, & Colin Diffie, MD  |  August 7, 2025

This report presents a rare case of bilateral pulmonary artery stenosis secondary to granulomatosis with polyangiitis, underscoring the importance of recognizing large-vessel involvement as a potential manifestation of AAV; it also includes a narrative review analyzing eight previously reported cases.

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitiscase reportFellows Forumgranulomatosis with polyangiitislarge-vessel vasculitisPulmonary Artery StenosisPulmonary Artery Stentingpulmonary hypertension

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 245
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences